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Background
ApoER2, a member of the LDL receptor family, binds to
reelin, triggering a signaling pathway that regulates neuro-
nal migration and positioning in the developing brain and
dendritic ramification. In the adult, reelin participates in
neuronal survival, synaptic plasticity and neurogenesis.
Our interest has been to study cell biology aspects of
ApoER2, including the molecular and cellular determi-
nants of its endocytic trafficking, how these features regu-
late the receptor signaling properties and ApoER2
participation in neurodegenerative conditions, such as Alz-
heimer’s Disease and in the Niemann Pick Type C disease
(NPC), a lipid storage and neurodegenerative disorder
caused by genetic mutations in npc1 gene that causes cho-
lesterol accumulation in late endosome/lysosomes. In
NPC there are alterations in the trafficking and signaling
of some receptors however this remains unexplored for
ApoER2. As APP, ApoER2 is also processed by proteases
and these events are regulated by ligand binding and some
cytosolic proteins such as Dab1. By yeast two-hybrid it
was found that ApoER2 binds to SNX17, a cytosolic pro-
tein that regulates trafficking of membrane proteins in the
early endosomal pathway. However SNX17 role in
ApoER2 trafficking and signaling has not been evaluated.
Methods
Endocytic trafficking (internalization and/or recycling) and
processing of ApoER2 was evaluated in cell lines trans-
fected with different forms of the receptor to determine
the role of 1) its NPxY motif and proline rich insert pre-
sent in the cytoplasmic domain, 2) Lipid rafts association,
3) dominant negative expression or silencing of adaptor
proteins such as Dab2 and SNX17 4) Intracellular choles-
terol accumulation. ApoER2 signaling in different condi-
tions (silencing of SNX17; late endosome/lysosome
cholesterol accumulation mimicking the NPC condition)
were performed in primary cultured neurons activated by
reelin, analyzing dendritic branching and determinations
of signaling proteins by Western blot.
Results
ApoER2 internalization is clathrin mediated, determined by
its NPXY motif and the adaptor protein Dab2. Lipid rafts
association or the presence of the proline-rich insert do not
modulate the receptor internalization. The NPXY motif is
also responsible of the recycling of ApoER2 from the early
endosome, which is mediated by SNX17. Abolishing
SNX17 affects ApoER2 signaling in neurons and the recep-
tor processing. ApoER2 processing is stimulated by its own
ligand reelin but also by activation of other signaling recep-
tors. In cellular conditions miming NPC there was a
decrease in ApoER2 surface levels, explained by a more effi-
cient internalization and less recycling. NPC neurons,
exhibited less dendritic ramification while the number of
apoptotic cells was increased. Both effects were partial but
significantly rescued when exogenous Reelin was added.
We found relevant differences in the expression of ApoER2
and its ligand reelin in the brains of the NPC KO mice.
Conclusions
ApoER2/Reelin signaling depends on the receptor’st r a f -
ficking and, in NPC, signaling is partially but significantly
active indicating that it could act as a survival mechanism
in this neurodegenerative disease. Supported by FONDE-
CYT 1110382 and MINREB.
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